<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30931713</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1933-6969</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Channels (Austin, Tex.)</Title>
          <ISOAbbreviation>Channels (Austin)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Overlap of periodic paralysis and paramyotonia congenita caused by SCN4A gene mutations two family reports and literature review.</ArticleTitle>
        <Pagination>
          <StartPage>110</StartPage>
          <EndPage>119</EndPage>
          <MedlinePgn>110-119</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/19336950.2019.1600967</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To verify the diagnosis of channelopathies in two families and explore the mechanism of the overlap between periodic paralysis (PP) and paramyotonia congenita (PMC).</AbstractText>
          <AbstractText Label="METHODS">We have studied two cases with overlapping symptoms of episodic weakness and stiffness in our clinical center using a series of assessment including detailed medical history, careful physical examination, laboratory analyses, muscle biopsy, electrophysiological evaluation, and genetic analysis.</AbstractText>
          <AbstractText Label="RESULTS">The first proband and part of his family with the overlap of PMC and hyperkalemic periodic paralysis (HyperPP) has been identified as c.2111C &gt; T (T704M) substitution of the gene SCN4A. The second proband and part of his family with the overlap of PMC and hypokalemic periodic paralysis type 2 (HypoPP2) has been identified as c.4343G &gt; A (R1448H) substitution of the gene SCN4A. In addition, one member of the second family with overlapping symptoms has been identified as a novel mutation c.2111C &gt; T without the mutation c.4343G &gt; A.</AbstractText>
          <AbstractText Label="CONCLUSIONS">SCN4A gene mutations can cause the overlap of PMC and PP (especially the HypoPP2). The clinical symptoms of episodic weakness and stiffness could happen at a different time or temperature. Based on diagnosis assessments such as medical history and muscle biopsy, further evaluations on long-time exercise test, genetic analysis, and patch clamp electrophysiology test need to be done in order to verify the specific subtype of channelopathies. Furthermore, the improvement of one member in the pregnancy period can be used as a reference for the other female in the child-bearing period with T704M.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Shan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>a First Clinical Medical College , Shanxi Medical University , Taiyuan , China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Neurology, First Affiliated Hospital , Shanxi Medical University , Taiyuan , China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Xueli</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Neurology, First Affiliated Hospital , Shanxi Medical University , Taiyuan , China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>Junhong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Neurology, First Affiliated Hospital , Shanxi Medical University , Taiyuan , China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Channels (Austin)</MedlineTA>
        <NlmUniqueID>101321614</NlmUniqueID>
        <ISSNLinking>1933-6950</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D062553">NAV1.4 Voltage-Gated Sodium Channel</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C106251">SCN4A protein, human</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020967" MajorTopicYN="N">Myotonic Disorders</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062553" MajorTopicYN="N">NAV1.4 Voltage-Gated Sodium Channel</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020513" MajorTopicYN="N">Paralysis, Hyperkalemic Periodic</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y"> gene</Keyword>
        <Keyword MajorTopicYN="Y">hyperkalemic periodic paralysis</Keyword>
        <Keyword MajorTopicYN="Y">hypokalemic periodic paralysis type 2</Keyword>
        <Keyword MajorTopicYN="Y">paramyotonia congenita</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30931713</ArticleId>
        <ArticleId IdType="pmc">PMC6527082</ArticleId>
        <ArticleId IdType="doi">10.1080/19336950.2019.1600967</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>McManis PG, Lambert EH, Daube JR.. 
The exercise test in periodic paralysis. Muscle Nerve. 1986;9:704–710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3785281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fournier E, Arzel M, Sternberg D, et al. 
Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol. 2004;56:650–661.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15389891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuntzer T, Flocard F, Vial C, et al. 
Exercise test in muscle channelopathies and other muscle disorders. Muscle Nerve. 2000;23:1089–1094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10883004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cannon SC.
Channelopathies of skeletal muscle excitability. Compr Physiol. 2015;5:761–790.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4754081</ArticleId>
            <ArticleId IdType="pubmed">25880512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding ZY.
The value of exercise test in the diagnosis of primary periodic paralysis [Doctoral dissertation]. Peking Union Medical College; 2008. 
Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Ding ZY, Cui LY. 
Value of exercise test in the diagnosis of periodic paralysis. Chin J Neuroimmunol Neurol. 2008;1:69–71. Chinese.</Citation>
        </Reference>
        <Reference>
          <Citation>Ding ZY, Liu MS, Cui LY. 
Reference value of long-time exercise test in the diagnosis of primary periodic paralysis. Chin Med J (Engl). 2014;127(18):3219–3223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25266516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>George AJ, Komisarof J, Kallen RG, et al. 
Primary structure of the adult human skeletal muscle voltage-dependent sodium channel. Ann Neurol. 1992;31:131–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1315496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McClatchey AI, Cannon SC, Slaugenhaupt SA, et al. 
The cloning and expression of a sodium channel beta 1-subunit cDNA from human brain. Hum Mol Genet. 1993;2:745–749.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8394762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calhoun JD, Isom LL. 
The role of non-pore-forming beta subunits in physiology and pathophysiology of voltage-gated sodium channels. Handb Exp Pharmacol. 2014;221:51–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24737232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cannon SC.
Sodium channelopathies of skeletal muscle. Handb Exp Pharmacol. 2018;246:309–330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5866235</ArticleId>
            <ArticleId IdType="pubmed">28939973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brancati F, Valente EM, Davies NP, et al. 
Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J Neurol Neurosurg Psychiatry. 2003;74:1339–1341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1738672</ArticleId>
            <ArticleId IdType="pubmed">12933953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelly P, Yang WS, Costigan D, et al. 
Paramyotonia congenita and hyperkalemic periodic paralysis associated with a Met 1592 Val substitution in the skeletal muscle sodium channel alpha subunit – a large kindred with a novel phenotype. Neuromuscul Disord. 1997;7:105–111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9131651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McClatchey AI, McKenna-Yasek D, Cros D, et al. 
Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel. Nat Genet. 1992;2:148–152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1338909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cannon SC.
Voltage-sensor mutations in channelopathies of skeletal muscle. J Physiol. 2010;588:1887–1895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2901977</ArticleId>
            <ArticleId IdType="pubmed">20156847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreau A, Gosselin-Badaroudine P, Chahine M. 
Molecular biology and biophysical properties of ion channel gating pores. Q Rev Biophys. 2014;47:364–388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25382261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matthews E, Labrum R, Sweeney MG, et al. 
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology. 2009;72:1544–1547.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2848101</ArticleId>
            <ArticleId IdType="pubmed">19118277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gosselin-Badaroudine P, Delemotte L, Moreau A, et al. 
Gating pore currents and the resting state of NaV1.4 voltage sensor domains. Proc Natl Acad Sci U S A. 2012;109:19250–19255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3511134</ArticleId>
            <ArticleId IdType="pubmed">23134726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delwaide PJ, Penders CA. 
Familial paramyotonia and paretic crises with hypokalemia. Rev Neurol (Paris). 1971;125:287–297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5153341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Streib EW.
Hypokalemic paralysis in two patients with paramyotonia congenita (PC) and known hyperkalemic/exercise-induced weakness. Muscle Nerve. 1989;12:936–937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2608088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Osch T, Stunnenberg BC, Sternberg D, et al. 
Prolonged attacks of weakness with hypokalemia in SCN4A-related paramyotonia congenita. Muscle Nerve. 2018;58:27–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30028520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohammadi B, Mitrovic N, Lehmann-Horn F, et al. 
Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V. J Physiol. 2003;547:691–698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2342724</ArticleId>
            <ArticleId IdType="pubmed">12562902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lehmann-Horn F, Jurkat-Rott K, Rudel R. 
Periodic paralysis: understanding channelopathies. Curr Neurol Neurosci Rep. 2002;2:61–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11898585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finsterer J.
Primary periodic paralyses. Acta Neurol Scand. 2008;117:145–158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18031562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finsterer J.
Disappearance of episodic weakness during pregnancy in hyperkalemic periodic paralysis from the SCNA4 mutation T704M. Neurologist. 2009;15:289–290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19741438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finsterer J, Wakil SM, Laccone F. 
Pregnancy reduces severity and frequency of attacks in hyperkalemic periodic paralysis due to the mutation c.2111C&gt;T in the SCN4A gene. Ann Indian Acad Neurol. 2017;20:75–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5341276</ArticleId>
            <ArticleId IdType="pubmed">28298850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakmann B, Neher E. 
Patch clamp techniques for studying ionic channels in excitable membranes. Annu Rev Physiol. 1984;46:455–472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6143532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li T, Lu G, Chiang EY, et al. 
High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE. PLoS One. 2017;12(7):e0180154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5500279</ArticleId>
            <ArticleId IdType="pubmed">28683073</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
